35.25
price down icon0.79%   -0.28
after-market After Hours: 35.25
loading
Biolife Solutions Inc stock is traded at $35.25, with a volume of 344.31K. It is down -0.79% in the last 24 hours and up +8.39% over the past month. BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
See More
Previous Close:
$35.53
Open:
$35.07
24h Volume:
344.31K
Relative Volume:
0.32
Market Cap:
$1.72B
Revenue:
$96.21M
Net Income/Loss:
$-12.13M
P/E Ratio:
-112.62
EPS:
-0.313
Net Cash Flow:
$10.64M
1W Performance:
-3.11%
1M Performance:
+8.39%
6M Performance:
+70.54%
1Y Performance:
+36.26%
1-Day Range:
Value
$34.89
$35.52
1-Week Range:
Value
$34.89
$37.25
52-Week Range:
Value
$17.86
$38.10

Biolife Solutions Inc Stock (BLFS) Company Profile

Name
Name
Biolife Solutions Inc
Name
Phone
(425) 401-1400
Name
Address
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Name
Employee
155
Name
Twitter
@biolifesol
Name
Next Earnings Date
2026-08-06
Name
Latest SEC Filings
Name
BLFS's Discussions on Twitter

Compare BLFS vs ISRG, BDX, ALC, RMD, MDLN

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
BLFS icon
BLFS
Biolife Solutions Inc
35.25 1.81B 96.21M -12.13M 10.64M -0.313
ISRG icon
ISRG
Intuitive Surgical Inc
366.70 132.30B 11.03B 3.16B 3.22B 8.7251
BDX icon
BDX
Becton Dickinson Co
184.74 51.11B 21.37B 1.41B 3.07B 3.9437
ALC icon
ALC
Alcon Inc
70.50 35.25B 10.63B 819.00M 1.59B 1.6577
RMD icon
RMD
Resmed Inc
228.35 32.95B 5.54B 1.52B 1.74B 10.37
MDLN icon
MDLN
Medline Inc
36.59 28.58B 29.14B 1.07B 1.05B 1.1956

Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-22-25 Resumed Stephens Overweight
Sep-30-24 Initiated H.C. Wainwright Buy
Apr-04-24 Initiated Jefferies Buy
Jul-11-23 Initiated Craig Hallum Buy
Apr-25-22 Upgrade Oppenheimer Perform → Outperform
Oct-19-21 Initiated B. Riley Securities Buy
Oct-15-21 Resumed Cowen Outperform
May-14-21 Downgrade The Benchmark Company Buy → Hold
Mar-23-21 Upgrade The Benchmark Company Hold → Buy
Nov-10-20 Initiated KeyBanc Capital Markets Overweight
Sep-22-20 Downgrade Oppenheimer Outperform → Perform
Sep-18-20 Initiated Cowen Outperform
Aug-11-20 Downgrade The Benchmark Company Buy → Hold
Jul-08-20 Reiterated Maxim Group Buy
Feb-24-20 Initiated Lake Street Buy
Feb-19-20 Initiated The Benchmark Company Buy
Feb-06-20 Resumed B. Riley FBR Buy
Jan-08-20 Initiated Stephens Overweight
Nov-21-19 Initiated Oppenheimer Outperform
Jul-22-19 Initiated H.C. Wainwright Buy
Nov-10-17 Reiterated Maxim Group Buy
Sep-19-17 Reiterated Maxim Group Buy
Jul-05-17 Upgrade Janney Neutral → Buy
Mar-10-17 Reiterated Maxim Group Buy
Jan-19-17 Initiated Maxim Group Buy
View All

Biolife Solutions Inc Stock (BLFS) Latest News

pulisher
Aug 21, 2026

Bank of America Corp DE Increases Stake in BioLife Solutions, Inc. $BLFS - MarketBeat

Aug 21, 2026
pulisher
Aug 19, 2026

Summit Creek Advisors LLC Acquires New Position in BioLife Solutions, Inc. $BLFS - MarketBeat

Aug 19, 2026
pulisher
Aug 18, 2026

BioLife Solutions Reports Fourth Quarter and Full Year 2025 Fina - GuruFocus

Aug 18, 2026
pulisher
Aug 18, 2026

Diamond Hill Capital Management LLC Investment Advisor Acquires New Stake in BioLife Solutions, Inc. $BLFS - MarketBeat

Aug 18, 2026
pulisher
Aug 18, 2026

Short Interest in BioLife Solutions, Inc. (NASDAQ:BLFS) Rises By 59.1% - MarketBeat

Aug 18, 2026
pulisher
Aug 17, 2026

BLFS Q2 2026 Earnings: EPS Beats Consensus by 17.65% as Shares Gain 1.08%Earnings Call Q&A - vinanet.vn

Aug 17, 2026
pulisher
Aug 17, 2026

BioLife Solutions (NASDAQ:BLFS) Reaches New 12-Month HighShould You Buy? - MarketBeat

Aug 17, 2026
pulisher
Aug 17, 2026

Biolife Solutions stock hits 52-week high at 35.36 USD By Investing.com - Investing.com South Africa

Aug 17, 2026
pulisher
Aug 17, 2026

Biolife Solutions stock hits 52-week high at 35.36 USD - Investing.com

Aug 17, 2026
pulisher
Aug 17, 2026

BioLife’s Sharp Swing To Profit Might Change The Case For Investing In BioLife Solutions (BLFS) - simplywall.st

Aug 17, 2026
pulisher
Aug 17, 2026

Roubaix Capital, LLC's BioLife Solutions Inc(BLFS) Holding History - GuruFocus

Aug 17, 2026
pulisher
Aug 16, 2026

BioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Aug 16, 2026
pulisher
Aug 12, 2026

BioLife Solutions, Inc. (BLFS) Stock Forecasts - Yahoo! Finance Canada

Aug 12, 2026
pulisher
Aug 11, 2026

BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating a High Forward P/E Amid Robust Growth in the Healthcare Sector - DirectorsTalk Interviews

Aug 11, 2026
pulisher
Aug 11, 2026

BioLife Solutions (NASDAQ:BLFS) Hits New 12-Month HighTime to Buy? - MarketBeat

Aug 11, 2026
pulisher
Aug 10, 2026

BioLife Solutions Cut to Hold From Buy by Benchmark - Moomoo

Aug 10, 2026
pulisher
Aug 10, 2026

Why BioLife Solutions (BLFS) Is Up 7.8% After Swinging To Q2 Profitability And What's Next - simplywall.st

Aug 10, 2026
pulisher
Aug 10, 2026

Benchmark Co. Downgrades BioLife Solutions(BLFS.US) to Hold Rating - Moomoo

Aug 10, 2026
pulisher
Aug 07, 2026

BioLife Solutions (BLFS) Stock Price Ignores A Sharp Turn To Profit - simplywall.st

Aug 07, 2026
pulisher
Aug 07, 2026

BioLife Solutions Inc (BLFS) Stock News Today - TradingKey

Aug 07, 2026
pulisher
Aug 07, 2026

BioLife Solutions Inc (BLFS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 07, 2026
pulisher
Aug 07, 2026

Royal Bank of Canada Purchases 66,010 Shares of BioLife Solutions, Inc. $BLFS - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

BLFS Looks 16.4% Overvalued on GF Value™ Amid Strong Q2 Revenue Beat - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 ProfitWhat's Changed - Yahoo Finance

Aug 07, 2026
pulisher
Aug 07, 2026

Is BioLife Solutions Inc (BLFS) Overvalued After Q2 Earnings Bea - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

BLFS SWOT Analysis: Strong Revenue Growth Amidst Strategic Changes Revealed in 10-Q Filing - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

BioLife Solutions (NASDAQ:BLFS) Posts Earnings Results, Beats Estimates By $0.88 EPS - MarketBeat

Aug 07, 2026
pulisher
Aug 06, 2026

BLFS Technical Analysis & Stock Price Forecast - Intellectia AI

Aug 06, 2026
pulisher
Aug 06, 2026

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

BioLife Solutions, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

BioLife Solutions 2026: Revenue $28.47M, EPS $0.91— 10-Q Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Earnings Flash (BLFS) BioLife Solutions, Inc. Reports Q2 Revenue $28.5M, vs. FactSet Est of $27.8M - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

BIOLIFE SOLUTIONS ($BLFS) Releases Q2 2026 Earnings - Quiver Quantitative

Aug 06, 2026
pulisher
Aug 06, 2026

BioLife Solutions (NASDAQ: BLFS) plans cash-stock merger with Repligen - Stock Titan

Aug 06, 2026
pulisher
Aug 06, 2026

BioLife Solutions reports Q2 2026 revenue $28.5M, GAAP net income $45.1M, adjusted EBITDA $7.4M - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

BioLife Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

BLFS: Q2 2026 revenue up 21% year-over-year; $1.5B acquisition by Repligen set for Q4 2026 - TradingView

Aug 06, 2026
pulisher
Aug 05, 2026

BioLife Solutions (NASDAQ:BLFS) Hits New 52-Week HighStill a Buy? - MarketBeat

Aug 05, 2026
pulisher
Aug 05, 2026

BioLife Solutions set to report earnings under takeover cloud By Investing.com - Investing.com Nigeria

Aug 05, 2026
pulisher
Aug 05, 2026

Biolife Solutions stock hits 52-week high at 33.18 USD - Investing.com

Aug 05, 2026
pulisher
Aug 05, 2026

Biolife Solutions stock hits 52-week high at 33.18 USD By Investing.com - Investing.com South Africa

Aug 05, 2026
pulisher
Aug 05, 2026

BioLife Solutions set to report earnings under takeover cloud - Investing.com

Aug 05, 2026
pulisher
Aug 04, 2026

Repligen Corporation (BLFS) sets cash and stock terms for BioLife Solutions buyout - stocktitan.net

Aug 04, 2026
pulisher
Aug 04, 2026

BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating Growth with Precision in the Healthcare Sector - DirectorsTalk Interviews

Aug 04, 2026
pulisher
Aug 03, 2026

Repligen to acquire BioLife Solutions in two-step merger; employee video details timeline - TradingView

Aug 03, 2026
pulisher
Aug 02, 2026

BLFS Q1 2026 Earnings: Marginal EPS Miss Highlights Narrow Beat-and-Miss GapEarnings Miss Streak - Vinanet

Aug 02, 2026
pulisher
Aug 01, 2026

BioLife Solutions, Inc. Revenue Breakdown – NASDAQ:BLFS - TradingView

Aug 01, 2026
pulisher
Jul 31, 2026

BLFS Q1 2026 Earnings: EPS of $0.02 Slightly Misses Consensus EstimatesShort-Term Outlook - Vinanet

Jul 31, 2026
pulisher
Jul 30, 2026

BLFS Q2'26 Earnings: revenue estimate is 27.80M USD - TradingView

Jul 30, 2026
pulisher
Jul 28, 2026

Avoiding Lag: Real-Time Signals in (BLFS) Movement - Stock Traders Daily

Jul 28, 2026
pulisher
Jul 28, 2026

Biolife Solutions stock hits 52-week high at 32.24 USD By Investing.com - Investing.com South Africa

Jul 28, 2026

Biolife Solutions Inc Stock (BLFS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Biolife Solutions Inc Stock (BLFS) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Casdin Partners Master Fund, L
10% Owner
May 19 '26
Sale
22.65
300,000
6,795,000
5,657,165
Casdin Partners Master Fund, L
10% Owner
May 20 '26
Sale
23.70
250,000
5,925,000
5,407,165
$158.63
price down icon 0.76%
BAX BAX
$25.83
price up icon 1.02%
COO COO
$69.59
price down icon 1.49%
$91.69
price down icon 0.81%
WST WST
$339.97
price down icon 0.81%
$36.59
price up icon 0.00%
Cap:     |  Volume (24h):